Brighter extends the agreement with Erik Lissner as acting CEO with an agreement of permanent employment from June 16
Brighter AB (Publ) announced today that its Board of Directors will extend the agreement with Erik Lissner as Acting CEO of Brighter until 15 June 2022 and that an agreement on permanent employment will commence thereafter.
"Erik is doing a great job and I am very happy that we have extended the agreement, which will be transformed into a permanent agreement this summer. Erik has extensive experience in the MedTech sector and has in a short time managed to push through the changes that are necessary to bring Brighter to market. I feel confident that he and the team at Brighter continue to run the company towards new upcoming milestones." says Christer Trägårdh, Chairman of the Board of Brighter AB
For more information, please contact:
Investor Relations
ir@brighter.se
Certified Adviser
Brighter's Certified Adviser is Eminova Fondkommission AB
+46 [0)8 - 684 211 10
adviser@eminova.se,www.eminova.se.
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter's quality management system is ISO-13485 certified. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG. https://brighter.se/
This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 17:05 CET on January 17, 2022